Related Experiment Video
Updated: Aug 17, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
A genetic study of red cell osmotic fragility in Huntington's disease
Insights
Individuals with Huntington's disease and those at risk show reduced erythrocyte osmotic fragility. This finding in red blood cells suggests a potential biomarker for Huntington's disease, warranting further investigation.
Area of Science:
- Neuroscience
- Genetics
- Hematology
Background:
- Huntington's disease (HD) is a complex behavioral genetic disorder.
- Erythrocyte osmotic fragility (EOF) is a measure of red blood cell stability.
- Alterations in EOF may be associated with neurological conditions.
Purpose of the Study:
- To investigate erythrocyte osmotic fragility in individuals with Huntington's disease and those at genetic risk.
- To determine if reduced EOF is a potential indicator in Huntington's disease progression or risk.
Main Methods:
- Evaluated EOF using a fragility index in subjects with Huntington's disease, individuals at 50% and 25% risk, and healthy controls.
- Analyzed osmotic fragility of fresh and incubated red blood cells.
- Compared fragility indices across different risk groups and controls.
Main Results:
- Huntington's disease patients exhibited statistically significant reduced erythrocyte osmotic fragility compared to controls (P < .001).
- A notable percentage of individuals at 50% risk (45%) and 25% risk (22.2%) also showed decreased osmotic fragility.
- Varied fragility patterns were observed in offspring of at-risk parents, suggesting complex inheritance patterns.
Conclusions:
- Data support the hypothesis of reduced erythrocyte osmotic fragility in individuals affected with or at risk for Huntington's disease.
- Reduced EOF may serve as a potential biomarker for Huntington's disease.
- Further research into erythrocyte function in Huntington's disease is warranted.
Abstract:
The erythrocyte osmotic fragility was evaluated on 19 unmedicated subjects with Huntington's disease and 42 individuals at 50% risk, 27 children at 25% risk, and a group of 60 hematologically normal control persons. Five older subjects at 50% risk for Huntington's disease as well as 6 Alzheimer's disease individuals were also evaluated for comparison. The osmotic fragility of fresh and 24-hour incubated red cells was analyzed and a fragility index calculated for each individual. The fragility index for the Huntington's disease group was statistically lower than that of the control group (P less than .001) suggesting that the Huntington's disease erythrocytes had a reduced osmotic fragility. In the 50% risk group, 45% of the subjects demonstrated decreased osmotic fragility and 55% had normal fragility. For those subjects in the 25% risk group, 22.2% had decreased fragility and 77.8% had normal fragility. Twenty-seven offspring were evaluated of the 14 persons at 50% risk for Huntington's disease with children; eight of the 14 individuals at 50% risk showed normal fragility and all 16 of their children showed fragility indices with the normal range. The remaining six persons at 50% risk for Huntington's disease had increased erythrocyte fragility and out of their 11 children, five showed normal fragility and six had decreased fragility. These data support the hypothesis of reduced erythrocyte osmotic fragility in individuals affected with and at risk for Huntington disease, and demonstrate the need of further study of the erythrocyte in this complex behavioral genetic disease.
More Related Videos
Related Concept Videos
Genetic Lingo
Huntington Disease l: Introduction

